हमारा समूह 1000 से अधिक वैज्ञानिक सोसायटी के सहयोग से हर साल संयुक्त राज्य अमेरिका, यूरोप और एशिया में 3000+ वैश्विक सम्मेलन श्रृंखला कार्यक्रम आयोजित करता है और 700+ ओपन एक्सेस जर्नल प्रकाशित करता है जिसमें 50000 से अधिक प्रतिष्ठित व्यक्तित्व, प्रतिष्ठित वैज्ञानिक संपादकीय बोर्ड के सदस्यों के रूप में शामिल होते हैं।
ओपन एक्सेस जर्नल्स को अधिक पाठक और उद्धरण मिल रहे हैं
700 जर्नल और 15,000,000 पाठक प्रत्येक जर्नल को 25,000+ पाठक मिल रहे हैं
Kinam Zhiang
Sentinel lymph node biopsy (SLNB) has evolved as a crucial technique in surgical oncology, revolutionizing cancer staging and therapeutic decision-making across various malignancies. This comprehensive review explores the clinical applications of SLNB, spanning the spectrum from melanoma to breast cancer. By focusing on these distinct tumor types, we aim to highlight the versatility and impact of SLNB in diverse clinical scenarios. In melanoma, SLNB has emerged as a gold standard for nodal staging, allowing for precise identification of sentinel lymph nodes and facilitating early detection of metastatic disease. We discuss the evolving role of SLNB in melanoma management, addressing its diagnostic accuracy, prognostic significance, and influence on treatment strategies. Breast cancer represents another area where SLNB has made significant inroads. Its utilization has enabled clinicians to tailor surgical approaches and adjuvant therapies, minimizing unnecessary axillary dissections and their associated morbidity. We examine the current guidelines and controversies surrounding SLNB in breast cancer, shedding light on its integration into multidisciplinary care.